company background image
PHIL logo

Philadelphia Pharmaceuticals ASE:PHIL Stock Report

Last Price

د.أ1.45

Market Cap

د.أ10.9m

7D

0%

1Y

11.5%

Updated

15 Jun, 2024

Data

Company Financials

Philadelphia Pharmaceuticals Company

ASE:PHIL Stock Report

Market Cap: د.أ10.9m

PHIL Stock Overview

Develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.

PHIL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends3/6

Philadelphia Pharmaceuticals Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Philadelphia Pharmaceuticals
Historical stock prices
Current Share Priceد.أ1.45
52 Week Highد.أ1.49
52 Week Lowد.أ1.34
Beta0.010
1 Month Change6.62%
3 Month Change-2.68%
1 Year Change11.54%
3 Year Change3.57%
5 Year Change-12.12%
Change since IPO108.33%

Recent News & Updates

Recent updates

Shareholder Returns

PHILJO PharmaceuticalsJO Market
7D0%-1.0%-0.9%
1Y11.5%1.5%-5.2%

Return vs Industry: PHIL exceeded the JO Pharmaceuticals industry which returned 1.5% over the past year.

Return vs Market: PHIL exceeded the JO Market which returned -5.2% over the past year.

Price Volatility

Is PHIL's price volatile compared to industry and market?
PHIL volatility
PHIL Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement3.7%
10% most volatile stocks in JO Market6.0%
10% least volatile stocks in JO Market2.3%

Stable Share Price: PHIL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PHIL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993133Ashraf Ahmad Husseinwww.philapharma.com

Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan. The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti-pruritic, anti-viral, plain antifungal and anti-infective, plain steroid, steroids with antifungal/anti-infective combination, and skin recoloring products. It also offers products for women health, such as vaginal antifungals, alkalinizing and cleansing agents, antimicrobials, germicidal fungicidal, antiseptics and hemostatic, and vaginal progesterone; and products in the areas of alimentary, gastrointestinal system, anti-inflammatory, analgesic, antipyretic, dental-oropharyngeal, hair care, local anesthetics, and respiratory system, as well as supplements and health care-OTC products.

Philadelphia Pharmaceuticals Company Fundamentals Summary

How do Philadelphia Pharmaceuticals's earnings and revenue compare to its market cap?
PHIL fundamental statistics
Market capد.أ10.88m
Earnings (TTM)د.أ831.25k
Revenue (TTM)د.أ8.72m

13.1x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHIL income statement (TTM)
Revenueد.أ8.72m
Cost of Revenueد.أ4.65m
Gross Profitد.أ4.07m
Other Expensesد.أ3.24m
Earningsد.أ831.25k

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin46.66%
Net Profit Margin9.53%
Debt/Equity Ratio19.2%

How did PHIL perform over the long term?

See historical performance and comparison

Dividends

4.8%

Current Dividend Yield

63%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.